Nanostructured porous silicon-mediated drug delivery

被引:15
作者
Martin-Palma, Raul J. [1 ]
Hernandez-Montelongo, Jacobo [1 ,2 ]
Torres-Costa, Vicente [1 ]
Manso-Silvan, Miguel [1 ]
Munoz-Noval, Alvaro [3 ]
机构
[1] Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain
[2] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Dept Fis Aplicada, BR-13083859 Campinas, SP, Brazil
[3] Spanish CRG ESRF, Inst Ciencia Mat Madrid CSIC, F-38000 Grenoble, France
关键词
composite; drug delivery; hybrid system; magnetic release; nanostructure; photoluminescence; porous silicon; CHEMICAL SURFACE MODIFICATION; MESOPOROUS SILICON; IN-VIVO; NANOPARTICLES; RELEASE; MICROPARTICLES; PARTICLES; CHEMISTRY; FABRICATION; CARRIER;
D O I
10.1517/17425247.2014.919254
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The particular properties of nanostructured porous silicon (nanoPS) make it an attractive material for controlled and localized release of therapeutics within the body, aiming at increased efficacy and reduced risks of potential side effects. Since this is a rapidly evolving field as a consequence of the number of research groups involved, a critical review of the state of the art is necessary. Areas covered: In this work, the most promising and successful applications of nanoPS in the field of drug delivery are reviewed and discussed. Two key issues such as drug loading and release are also analyzed in detail. The development of multifunctional (hybrid) systems, aiming at imparting additional functionalities to the nanoPS particles such as luminescence, magnetic response and/or plasmonic effects (allowing simultaneous tracking and guiding), is also examined. Expert opinion: Nanostructured materials based on silicon are promising platforms for pharmaceutical applications given their ability to degrade and low toxicity. However, a very limited number of clinical applications have been demonstrated so far.
引用
收藏
页码:1273 / 1283
页数:11
相关论文
共 79 条
[61]  
2-F
[62]   Fabrication and chemical surface modification of mesoporous silicon for biomedical applications [J].
Salonen, Jamo ;
Lehto, Vesa-Pekka .
CHEMICAL ENGINEERING JOURNAL, 2008, 137 (01) :162-172
[63]   Mesoporous silicon in drug delivery applications [J].
Salonen, Jarno ;
Kaukonen, Ann M. ;
Hirvonen, Jouni ;
Lehto, Vesa-Pekka .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) :632-653
[64]  
Santos H.A., 2014, Porous silicon for biomedical applications
[65]   Nanostructured porous silicon materials: potential candidates for improving drug delivery [J].
Santos, Helder A. ;
Hirvonen, Jouni .
NANOMEDICINE, 2012, 7 (09) :1281-1284
[66]   18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography [J].
Sarparanta, Mirkka ;
Makila, Ermei ;
Heikkila, Teemu ;
Salonen, Jarno ;
Kukk, Edwin ;
Lehto, Vesa-Pekka ;
Santos, Helder A. ;
Hirvonen, Jouni ;
Airaksinen, Anu J. .
MOLECULAR PHARMACEUTICS, 2011, 8 (05) :1799-1806
[67]   Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates [J].
Segal, Ester ;
Perelman, Loren A. ;
Cunin, Frederique ;
Di Renzo, Francesco ;
Devoisselle, Jean-Marie ;
Li, Yang Yang ;
Sailor, Michael J. .
ADVANCED FUNCTIONAL MATERIALS, 2007, 17 (07) :1153-1162
[68]   POROUS SILICON FORMATION MECHANISMS [J].
SMITH, RL ;
COLLINS, SD .
JOURNAL OF APPLIED PHYSICS, 1992, 71 (08) :R1-R22
[69]   Chemical modification of crystalline porous silicon surfaces [J].
Song, JH ;
Sailor, MJ .
COMMENTS ON INORGANIC CHEMISTRY, 1999, 21 (1-3) :69-84
[70]  
Stewart MP, 2000, ADV MATER, V12, P859, DOI 10.1002/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO